BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10888468)

  • 1. Nitric oxide: a unique endogenous signaling molecule in vascular biology.
    Ignarro LJ
    Biosci Rep; 1999 Apr; 19(2):51-71. PubMed ID: 10888468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 1998 Nobel Prize--discovery of the role of nitric oxide as a signalling molecule.
    Zetterström R
    Acta Paediatr; 2009 Mar; 98(3):593-9. PubMed ID: 19133871
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidative release of nitric oxide accounts for guanylyl cyclase stimulating, vasodilator and anti-platelet activity of Piloty's acid: a comparison with Angeli's salt.
    Zamora R; Grzesiok A; Weber H; Feelisch M
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):333-9. PubMed ID: 8526840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
    Severina IS
    Biull Eksp Biol Med; 1995 Mar; 119(3):230-5. PubMed ID: 7795182
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelium, anesthetics, and vascular control.
    Johns RA
    Anesthesiology; 1993 Dec; 79(6):1381-91. PubMed ID: 7505534
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions.
    Anderson TJ; Meredith IT; Ganz P; Selwyn AP; Yeung AC
    J Am Coll Cardiol; 1994 Aug; 24(2):555-66. PubMed ID: 8034895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Nobel Prize 1998 in physiology or medicine. Nitrogen oxide as a signal molecule in the cardiovascular system].
    Hansson GK; Jörnvall H; Lindahl SG
    Ugeskr Laeger; 1998 Dec; 160(52):7571-8. PubMed ID: 9889673
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [1998 Nobel Prize in physiology or medicine. Nitric oxide as a signal molecule in the cardiovascular system].
    Hansson GK; Jörnvall H; Lindahl SG
    Lakartidningen; 1998 Oct; 95(43):4703-8. PubMed ID: 9821753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS
    Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
    Salvemini D; Pistelli A; Anggard E
    Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of vascular homeostasis by nitric oxide.
    Radomski MW; Moncada S
    Thromb Haemost; 1993 Jul; 70(1):36-41. PubMed ID: 7694388
    [No Abstract]   [Full Text] [Related]  

  • 14. Discovery of some of the biological effects of nitric oxide and its role in cell signaling.
    Murad F
    Biosci Rep; 2004; 24(4-5):452-74. PubMed ID: 16134022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: a novel mechanism to explain preferential venodilation of organic nitrates.
    Kojda G; Patzner M; Hacker A; Noack E
    Mol Pharmacol; 1998 Mar; 53(3):547-54. PubMed ID: 9495823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A; Busse R; Bassenge E
    Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.
    Ignarro LJ
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):503-14. PubMed ID: 12512688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1998 Nobel Prizes in Science.
    Gibbs WW; Nemecek S; Stix G
    Sci Am; 1999 Jan; 280(1):16-9. PubMed ID: 10026073
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nitric oxide--more than a vasodilator].
    Persson MG; Wiklund NP; Gustafsson LE
    Lakartidningen; 1993 Apr; 90(14):1365-71. PubMed ID: 8479257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.